Compare NOMD & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOMD | ASTH |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Professional Services |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2015 | 2015 |
| Metric | NOMD | ASTH |
|---|---|---|
| Price | $10.66 | $35.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $12.50 | ★ $34.86 |
| AVG Volume (30 Days) | ★ 1.2M | 327.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $519,907,752.00 |
| Revenue This Year | N/A | $27.38 |
| Revenue Next Year | $1.45 | $10.78 |
| P/E Ratio | ★ $8.38 | $52.64 |
| Revenue Growth | N/A | ★ 45.90 |
| 52 Week Low | $8.99 | $18.08 |
| 52 Week High | $13.48 | $51.60 |
| Indicator | NOMD | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 36.14 | 45.20 |
| Support Level | $9.52 | $33.92 |
| Resistance Level | $12.16 | $40.08 |
| Average True Range (ATR) | 0.26 | 1.95 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 16.10 | 46.12 |
Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.